CureVac fails in pivotal Covid-19 vaccine trial with 47% efficacy
CureVac fails in pivotal Covid-19 vaccine trial with 47% efficacy
Jun 17, 2021, 8:15am UTC
https://www.reuters.com/business/healthcare-pharmaceuticals/curevacs-covid-19-vaccine-misses-efficacy-goal-mass-trial-2021-06-16/